Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline.

Fairbairn N, Ross J, Trew M, Meador K, Turnbull J, MacDonald S, Oviedo-Joekes E, Le Foll B, Goyer MÈ, Perreault M, Sutherland C.

CMAJ. 2019 Sep 23;191(38):E1049-E1056. doi: 10.1503/cmaj.190344. No abstract available.

2.

Density of low-barrier opioid agonist clinics and risk of non-fatal overdose during a community-wide overdose crisis: A spatial analysis.

Amram O, Socías E, Nosova E, Kerr T, Wood E, DeBeck K, Hayashi K, Fairbairn N, Montaner J, Milloy MJ.

Spat Spatiotemporal Epidemiol. 2019 Aug;30:100288. doi: 10.1016/j.sste.2019.100288. Epub 2019 Jul 4.

PMID:
31421798
3.

Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.

Mohd Salleh NA, Fairbairn N, Nolan S, Barrios R, Shoveller J, Richardson L, Milloy MJ.

HIV Med. 2019 Oct;20(9):606-614. doi: 10.1111/hiv.12777. Epub 2019 Jul 29.

PMID:
31359615
4.

Prescription of High-Dose Opioids Among People Living with HIV in British Columbia, Canada.

Clark J, Fairbairn N, Nolan S, Li T, Wu A, Barrios R, Montaner J, Ti L; STOP HIV/AIDS in BC Study Group.

AIDS Behav. 2019 Dec;23(12):3331-3339. doi: 10.1007/s10461-019-02589-3.

PMID:
31286318
5.

Criminal Justice System Involvement as a Risk Factor for Detectable Plasma HIV Viral Load in People Who Use Illicit Drugs: A Longitudinal Cohort Study.

Ickowicz S, Salleh NAM, Fairbairn N, Richardson L, Small W, Milloy MJ.

AIDS Behav. 2019 Sep;23(9):2634-2639. doi: 10.1007/s10461-019-02547-z.

PMID:
31236749
6.

Knowledge of Fentanyl and Perceived Risk of Overdose Among Persons Who Use Drugs in Vancouver, Canada.

Moallef S, Nosova E, Milloy MJ, DeBeck K, Fairbairn N, Wood E, Kerr T, Hayashi K.

Public Health Rep. 2019 Jul/Aug;134(4):423-431. doi: 10.1177/0033354919857084. Epub 2019 Jun 18.

PMID:
31211644
7.

Development and Evaluation of the Online Addiction Medicine Certificate: Free Novel Program in a Canadian Setting.

Gorfinkel LR, Giesler A, Dong H, Wood E, Fairbairn N, Klimas J.

JMIR Med Educ. 2019 May 24;5(1):e12474. doi: 10.2196/12474.

8.

Strategies to Identify Patient Risks of Prescription Opioid Addiction When Initiating Opioids for Pain: A Systematic Review.

Klimas J, Gorfinkel L, Fairbairn N, Amato L, Ahamad K, Nolan S, Simel DL, Wood E.

JAMA Netw Open. 2019 May 3;2(5):e193365. doi: 10.1001/jamanetworkopen.2019.3365.

9.

Slow release oral morphine versus methadone for the treatment of opioid use disorder.

Klimas J, Gorfinkel L, Giacomuzzi SM, Ruckes C, Socías ME, Fairbairn N, Wood E.

BMJ Open. 2019 Apr 2;9(4):e025799. doi: 10.1136/bmjopen-2018-025799.

10.

Correlates of opioid and benzodiazepine co-prescription among people living with HIV in British Columbia, Canada: A population-level cohort study.

Parent S, Nolan S, Fairbairn N, Ye M, Wu A, Montaner J, Barrios R, Ti L; STOP HIV AIDS Study Group.

Int J Drug Policy. 2019 May;67:52-57. doi: 10.1016/j.drugpo.2019.01.021. Epub 2019 Mar 18.

PMID:
30897373
11.

Comparing Canadian and United States opioid agonist therapy policies.

Priest KC, Gorfinkel L, Klimas J, Jones AA, Fairbairn N, McCarty D.

Int J Drug Policy. 2019 Dec;74:257-265. doi: 10.1016/j.drugpo.2019.01.020. Epub 2019 Feb 11.

PMID:
30765118
12.

In-hospital training in addiction medicine: A mixed-methods study of health care provider benefits and differences.

Gorfinkel L, Klimas J, Reel B, Dong H, Ahamad K, Fairgrieve C, McLean M, Mead A, Nolan S, Small W, Cullen W, Wood E, Fairbairn N.

Subst Abus. 2019;40(2):207-213. doi: 10.1080/08897077.2018.1561596. Epub 2019 Jan 28.

PMID:
30689528
13.

Interventions to address substance use and sexual risk among gay, bisexual and other men who have sex with men who use methamphetamine: A systematic review.

Knight R, Karamouzian M, Carson A, Edward J, Carrieri P, Shoveller J, Fairbairn N, Wood E, Fast D.

Drug Alcohol Depend. 2019 Jan 1;194:410-429. doi: 10.1016/j.drugalcdep.2018.09.023. Epub 2018 Nov 3.

PMID:
30502543
14.

Drug checking as a potential strategic overdose response in the fentanyl era.

Laing MK, Tupper KW, Fairbairn N.

Int J Drug Policy. 2018 Dec;62:59-66. doi: 10.1016/j.drugpo.2018.10.001. Epub 2018 Oct 22.

PMID:
30359874
15.

Characterizing fentanyl-related overdoses and implications for overdose response: Findings from a rapid ethnographic study in Vancouver, Canada.

Mayer S, Boyd J, Collins A, Kennedy MC, Fairbairn N, McNeil R.

Drug Alcohol Depend. 2018 Dec 1;193:69-74. doi: 10.1016/j.drugalcdep.2018.09.006. Epub 2018 Oct 12.

16.

Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada.

Bozinoff N, DeBeck K, Milloy MJ, Nosova E, Fairbairn N, Wood E, Hayashi K.

Drug Alcohol Depend. 2018 Dec 1;193:42-47. doi: 10.1016/j.drugalcdep.2018.09.003. Epub 2018 Oct 6.

17.

Factors associated with methadone maintenance therapy discontinuation among people who inject drugs.

Lo A, Kerr T, Hayashi K, Milloy MJ, Nosova E, Liu Y, Fairbairn N.

J Subst Abuse Treat. 2018 Nov;94:41-46. doi: 10.1016/j.jsat.2018.08.009. Epub 2018 Aug 23.

18.

High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.

Socías ME, Wood E, Lake S, Nolan S, Fairbairn N, Hayashi K, Shulha HP, Liu S, Kerr T, Milloy MJ.

Addiction. 2018 Dec;113(12):2250-2258. doi: 10.1111/add.14398. Epub 2018 Sep 20.

19.

Expanding supervised injection facilities across Canada: lessons from the Vancouver experience.

Young S, Fairbairn N.

Can J Public Health. 2018 Apr;109(2):227-230. doi: 10.17269/s41997-018-0089-7. Epub 2018 May 9.

20.

Integrating injectable opioid agonist treatment into a drug treatment court program: A case study.

Jun JH, Fairbairn N.

Subst Abus. 2018;39(4):493-496. doi: 10.1080/08897077.2018.1485129. Epub 2018 Oct 2.

21.

Patients With Substance Use Disorders Leaving Against Medical Advice: Strategies for Improvement.

Lail P, Fairbairn N.

J Addict Med. 2018 Nov/Dec;12(6):421-423. doi: 10.1097/ADM.0000000000000432.

22.

Nontraditional Alcohol and Opioid Agonist Treatment Interventions.

Fairgrieve C, Fairbairn N, Samet JH, Nolan S.

Med Clin North Am. 2018 Jul;102(4):683-696. doi: 10.1016/j.mcna.2018.02.006. Review.

23.

Willingness to use an in-hospital supervised inhalation room among people who smoke crack cocaine in Vancouver, Canada.

Cortina S, Kennedy MC, Dong H, Fairbairn N, Hayashi K, Milloy MJ, Kerr T.

Drug Alcohol Rev. 2018 Jul;37(5):645-652. doi: 10.1111/dar.12815. Epub 2018 Jun 5.

24.

Eligibility for heroin-assisted treatment (HAT) among people who inject opioids and are living with HIV in a Canadian setting.

Klimas J, Dong H, Fairbairn N, Socías E, Barrios R, Wood E, Kerr T, Montaner J, Milloy MJ.

Addict Sci Clin Pract. 2018 Feb 7;13(1):3. doi: 10.1186/s13722-017-0104-y.

25.

Prediction of three year outcomes using the Bayley-III for surgical, cardiac and healthy Australian infants at one year of age.

Fairbairn N, Galea C, Loughran-Fowlds A, Hodge A, Badawi N, Walker K.

Early Hum Dev. 2018 Feb;117:57-61. doi: 10.1016/j.earlhumdev.2017.12.012. Epub 2017 Dec 27.

PMID:
29288912
26.

Autologous breast reconstruction using the immediately lipofilled extended latissimus dorsi flap.

Johns N, Fairbairn N, Trail M, Ewing A, Yong L, Raine C, Dixon JM.

J Plast Reconstr Aesthet Surg. 2018 Feb;71(2):201-208. doi: 10.1016/j.bjps.2017.10.015. Epub 2017 Nov 24.

PMID:
29239797
27.

Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions.

Chang DC, Klimas J, Wood E, Fairbairn N.

Am J Drug Alcohol Abuse. 2018;44(2):143-146. doi: 10.1080/00952990.2017.1399403. Epub 2017 Nov 30.

28.

The relationship between hazardous alcohol use and violence among street-involved youth.

Fairbairn N, Wood E, Dobrer S, Dong H, Kerr T, Debeck K.

Am J Addict. 2017 Dec;26(8):852-858. doi: 10.1111/ajad.12643. Epub 2017 Nov 21.

29.

A Case of Opioid Overdose and Subsequent Death After Medically Supervised Withdrawal: The Problematic Role of Rapid Tapers for Opioid Use Disorder.

Chang DC, Klimas J, Wood E, Fairbairn N.

J Addict Med. 2018 Jan/Feb;12(1):80-83. doi: 10.1097/ADM.0000000000000359.

30.

Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.

Fairbairn N, Coffin PO, Walley AY.

Int J Drug Policy. 2017 Aug;46:172-179. doi: 10.1016/j.drugpo.2017.06.005. Epub 2017 Jul 4.

31.

Mortality in HIV-Infected Alcohol and Drug Users in St. Petersburg, Russia.

Fairbairn NS, Walley AY, Cheng DM, Quinn E, Bridden C, Chaisson C, Blokhina E, Lioznov D, Krupitsky E, Raj A, Samet JH.

PLoS One. 2016 Nov 29;11(11):e0166539. doi: 10.1371/journal.pone.0166539. eCollection 2016.

32.

Erratum: Light-Activated Sealing of Acellular Nerve Allografts following Nerve Gap Injury.

Fairbairn NG, Ng-Glazier J, Meppelink AM, Randolph MA, Valerio IL, Fleming ME, Kochevar IE, Winograd JM, Redmond RW.

J Reconstr Microsurg. 2016 Nov;32(9):e1. Epub 2016 Jun 24. No abstract available.

PMID:
27341523
33.

Hazardous Alcohol Use Associated with Increased Sexual Risk Behaviors Among People Who Inject Drugs.

Fairbairn N, Hayashi K, Milloy MJ, Nolan S, Nguyen P, Wood E, Kerr T.

Alcohol Clin Exp Res. 2016 Nov;40(11):2394-2400. doi: 10.1111/acer.13216. Epub 2016 Sep 17.

34.

Unsafe sexual behaviour associated with hazardous alcohol use among street-involved youth.

Fairbairn N, Wood E, Dong H, Kerr T, DeBeck K.

AIDS Care. 2017 Apr;29(4):481-488. doi: 10.1080/09540121.2016.1220480. Epub 2016 Aug 18.

35.

Improving Outcomes in Immediate and Delayed Nerve Grafting of Peripheral Nerve Gaps Using Light-Activated Sealing of Neurorrhaphy Sites with Human Amnion Wraps.

Fairbairn NG, Ng-Glazier J, Meppelink AM, Randolph MA, Winograd JM, Redmond RW.

Plast Reconstr Surg. 2016 Mar;137(3):887-95. doi: 10.1097/01.prs.0000479996.04255.60.

PMID:
26910669
36.

Light-Activated Sealing of Acellular Nerve Allografts following Nerve Gap Injury.

Fairbairn NG, Ng-Glazier J, Meppelink AM, Randolph MA, Valerio IL, Fleming ME, Kochevar IE, Winograd JM, Redmond RW.

J Reconstr Microsurg. 2016 Jul;32(6):421-30. doi: 10.1055/s-0035-1571247. Epub 2016 Feb 15. Erratum in: J Reconstr Microsurg. 2016 Nov;32(9):e1.

PMID:
26878685
37.

Commentary on Enns et al. (2016): Supervised injection facilities as a cost-effective intervention.

Fairbairn N, Wood E.

Addiction. 2016 Mar;111(3):490-1. doi: 10.1111/add.13242. No abstract available.

38.

Light-Activated Sealing of Nerve Graft Coaptation Sites Improves Outcome following Large Gap Peripheral Nerve Injury.

Fairbairn NG, Ng-Glazier J, Meppelink AM, Randolph MA, Valerio IL, Fleming ME, Winograd JM, Redmond RW.

Plast Reconstr Surg. 2015 Oct;136(4):739-50. doi: 10.1097/PRS.0000000000001617.

PMID:
26397251
39.

Augmenting peripheral nerve regeneration using stem cells: A review of current opinion.

Fairbairn NG, Meppelink AM, Ng-Glazier J, Randolph MA, Winograd JM.

World J Stem Cells. 2015 Jan 26;7(1):11-26. doi: 10.4252/wjsc.v7.i1.11. Review.

40.

Compulsory drug detention and injection drug use cessation and relapse in Bangkok, Thailand.

Fairbairn N, Hayashi K, Ti L, Kaplan K, Suwannawong P, Wood E, Kerr T.

Drug Alcohol Rev. 2015 Jan;34(1):74-81. doi: 10.1111/dar.12206. Epub 2014 Oct 10.

PMID:
25302711
41.

The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users.

Nolan S, Dias Lima V, Fairbairn N, Kerr T, Montaner J, Grebely J, Wood E.

Addiction. 2014 Dec;109(12):2053-9. doi: 10.1111/add.12682. Epub 2014 Aug 14.

42.

The clinical applications of human amnion in plastic surgery.

Fairbairn NG, Randolph MA, Redmond RW.

J Plast Reconstr Aesthet Surg. 2014 May;67(5):662-75. doi: 10.1016/j.bjps.2014.01.031. Epub 2014 Jan 31. Review.

PMID:
24560801
43.

Drug-related harm among people who inject drugs in Thailand: summary findings from the Mitsampan Community Research Project.

Hayashi K, Ti L, Fairbairn N, Kaplan K, Suwannawong P, Wood E, Kerr T.

Harm Reduct J. 2013 Oct 7;10:21. doi: 10.1186/1477-7517-10-21.

44.

The role of hybrid SPECT/CT for lymphatic mapping in patients with melanoma.

Fairbairn N, Munson C, Khan ZA, Butterworth M.

J Plast Reconstr Aesthet Surg. 2013 Sep;66(9):1248-55. doi: 10.1016/j.bjps.2013.04.062. Epub 2013 May 20.

PMID:
23697997
45.

Hyperspectral darkfield microscopy of single hollow gold nanoparticles for biomedical applications.

Fairbairn N, Christofidou A, Kanaras AG, Newman TA, Muskens OL.

Phys Chem Chem Phys. 2013 Mar 28;15(12):4163-8. doi: 10.1039/c2cp43162a.

PMID:
23183927
46.

Spatial modulation microscopy for real-time imaging of plasmonic nanoparticles and cells.

Fairbairn N, Light RA, Carter R, Fernandes R, Kanaras AG, Elliott TJ, Somekh MG, Pitter MC, Muskens OL.

Opt Lett. 2012 Aug 1;37(15):3015-7. doi: 10.1364/OL.37.003015.

PMID:
22859070
47.

Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.

Fairbairn NG, Orfaniotis G, Butterworth M.

J Plast Reconstr Aesthet Surg. 2012 Oct;65(10):1396-402. doi: 10.1016/j.bjps.2012.04.019. Epub 2012 May 1.

PMID:
22552263
48.

Findings of computed tomography in stage IIB and IIC melanoma: a six-year retrospective study in the South-East of Scotland.

Orfaniotis G, Mennie JC, Fairbairn N, Butterworth M.

J Plast Reconstr Aesthet Surg. 2012 Sep;65(9):1216-9. doi: 10.1016/j.bjps.2012.03.044. Epub 2012 Apr 21.

PMID:
22525255
49.

No such thing as "just" a nail bed injury.

Fairbairn N.

Pediatr Emerg Care. 2012 Apr;28(4):363-5. doi: 10.1097/PEC.0b013e31824d9d57.

PMID:
22472652
50.

Collective empowerment while creating knowledge: a description of a community-based participatory research project with drug users in Bangkok, Thailand.

Hayashi K, Fairbairn N, Suwannawong P, Kaplan K, Wood E, Kerr T.

Subst Use Misuse. 2012 Apr;47(5):502-10. doi: 10.3109/10826084.2012.644110.

PMID:
22428818

Supplemental Content

Loading ...
Support Center